Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Couvineau

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
British Journal of Pharmacology|December 15, 2024
Pharmacodynamics of the orexin type 1 (OX<sub>1</sub>) receptor in colon cancer cell models: A two-sided nature of antagonistic ligands resulting from partial dissociation of GqValérie Gratio, Paulina Dragan, Laurine Garcia, et al.
The Journal of Biological Chemistry|March 8, 2006
Peptide agonist docking in the N-terminal ectodomain of a class II G protein-coupled receptor, the VPAC1 receptor. Photoaffinity, NMR, and molecular modelingYossan-Var Tan, Alain Couvineau, Samuel Murail, et al.
Annals of the New York Academy of Sciences|August 5, 2006
The human VPAC1 receptor: identification of the N-terminal ectodomain as a major VIP-binding site by photoaffinity labeling and 3D modelingAlain Couvineau, Yossan-Var Tan, Emille Ceraudo, et al.
Molecular Endocrinology (Baltimore, Md.)|September 22, 2007
The vasoactive intestinal peptide (VIP) alpha-Helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamicsEmilie Ceraudo, Samuel Murail, Yossan-Var Tan, et al.
Biochimie|December 28, 2010
Identification by photoaffinity labeling of the extracellular N-terminal domain of PAC1 receptor as the major binding site for PACAPAgnieszka Dejda, Steve Bourgault, Ngoc Duc Doan, et al.
Journal of Medicinal Chemistry|May 6, 2009
Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptorSteve Bourgault, David Vaudry, Isabelle Ségalas-Milazzo, et al.
Molecular Pharmacology|December 4, 2003
Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptorJean-Claude Marie, Christiane Rouyer-Fessard, Alain Couvineau, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 30, 2010
Subtle conformational changes between CX3CR1 genetic variants as revealed by resonance energy transfer assaysKévin Darbandi-Tehrani, Patricia Hermand, Stéphanie Carvalho, et al.
Human Molecular Genetics|June 19, 2008
PTHR1 mutations associated with Ollier disease result in receptor loss of functionAlain Couvineau, Vinciane Wouters, Guylène Bertrand, et al.
The Journal of Biological Chemistry|November 26, 2002
Novel receptor partners and function of receptor activity-modifying proteinsArthur Christopoulos, George Christopoulos, Maria Morfis, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
British Journal of Pharmacology|December 15, 2024
Pharmacodynamics of the orexin type 1 (OX<sub>1</sub>) receptor in colon cancer cell models: A two-sided nature of antagonistic ligands resulting from partial dissociation of GqValérie Gratio, Paulina Dragan, Laurine Garcia, et al.
The Journal of Biological Chemistry|March 8, 2006
Peptide agonist docking in the N-terminal ectodomain of a class II G protein-coupled receptor, the VPAC1 receptor. Photoaffinity, NMR, and molecular modelingYossan-Var Tan, Alain Couvineau, Samuel Murail, et al.
Annals of the New York Academy of Sciences|August 5, 2006
The human VPAC1 receptor: identification of the N-terminal ectodomain as a major VIP-binding site by photoaffinity labeling and 3D modelingAlain Couvineau, Yossan-Var Tan, Emille Ceraudo, et al.
Molecular Endocrinology (Baltimore, Md.)|September 22, 2007
The vasoactive intestinal peptide (VIP) alpha-Helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamicsEmilie Ceraudo, Samuel Murail, Yossan-Var Tan, et al.
Biochimie|December 28, 2010
Identification by photoaffinity labeling of the extracellular N-terminal domain of PAC1 receptor as the major binding site for PACAPAgnieszka Dejda, Steve Bourgault, Ngoc Duc Doan, et al.
Journal of Medicinal Chemistry|May 6, 2009
Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptorSteve Bourgault, David Vaudry, Isabelle Ségalas-Milazzo, et al.
Molecular Pharmacology|December 4, 2003
Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptorJean-Claude Marie, Christiane Rouyer-Fessard, Alain Couvineau, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 30, 2010
Subtle conformational changes between CX3CR1 genetic variants as revealed by resonance energy transfer assaysKévin Darbandi-Tehrani, Patricia Hermand, Stéphanie Carvalho, et al.
Human Molecular Genetics|June 19, 2008
PTHR1 mutations associated with Ollier disease result in receptor loss of functionAlain Couvineau, Vinciane Wouters, Guylène Bertrand, et al.
The Journal of Biological Chemistry|November 26, 2002
Novel receptor partners and function of receptor activity-modifying proteinsArthur Christopoulos, George Christopoulos, Maria Morfis, et al.
Pageof 6